Prostate cancer types of cells

The hormone-sensitive cells die and the hormone-resistant cells overgrow, resulting in disease progression.

Which is Better - Surgery vs. Radiation for Prostate Cancer?

The drug of choice for secondary treatment is estramustine Estracyt. The success of the therapy is followed by changes of the prostate-specific antigen level and Karnofsky scale. In the present study, the results of estramustine treatment of 79 patients with advanced prostate cancer in 12 hospitals were evaluated.

Nivolumab treatment became the new standard of care in locally advanced or metastatic renal cell cancer after failure on tyrosine kinase inhibitor treatment.

The mean prostate-specific antigen level improved for 6 months, but rose from the ninth month on. The improvement in the subjective condition of the patients paralleled the change in the prostate-specific antigen level.

Aloe injekció amikor a prosztatitis Tinktúra a propolis prosztatitisen

The short time of improvement was a consequence of the very high prostate-specific antigen level and the poor general condition. Estramustine administration is recommended when the prostate-specific antigen level becomes more than doubled following primary treatment.

prostate cancer pathology Boligolov prostatitis tinktúra

If the prostate-specific antigen level has not decreased after treatment for 3 months, the secondary strategy is to apply chemotherapy. Publication types.

lenmag a prosztatitisből prosztatagyulladás kora

Fontos információk